<DOC>
	<DOC>NCT02002988</DOC>
	<brief_summary>The aim of this prospective non-randomized study was to assess the efficacy and safety of endomyocardial botulinum toxin injection in projections of main ganglionated plexuses of left atrium for preventing drug-resistant paroxysmal atrial fibrillation.</brief_summary>
	<brief_title>Botulinum Toxin Injection Prevent Paroxysmal Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>drugresistant PAF Previous heart surgery and AF ablation procedure Emergency CABG Unstable angina or heart failure Persistent AF, AF at the time of screening (planned Maze procedure or pulmonary vein isolation) Use of I or III antiarrhythmic drugs within 5 elimination halflives of the drug (or within 2 months for amiodarone) Requiring concomitant valve surgery Left ventricle ejection fraction &lt;35% Left atrial diameter &gt;55 mm Unwillingness to participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>